Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001193125-25-283953

Chief Accounting Officer bought 11,000 shares at $2.03 ($22,295)

From the SEC's structured data for this filing

Trades in this filing

Hunt Jonathan Robert · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-13 Purchase : show line 1 in the form +11,000 $2.03 $22,295 59,800 D
Open-market purchases · 11,000 sh · avg $2.03 · $22,295
Loading xslF345X05/ownership.xml…